Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
基本信息
- 批准号:10885455
- 负责人:
- 金额:$ 20.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-25 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdultAfrican AmericanAgreementAmericanAreaAsianAwardBiometryBlack raceBudgetsCaucasiansCessation of lifeChild HealthChildhoodClinicalClinical ResearchCommunitiesCommunity OutreachDelawareDevelopmentEpidemiologyEquityEthnic OriginEvaluationFundingGoalsGrantGrowthHealthHealth PromotionHealthcareHealthcare SystemsHispanicHospitalsInfrastructureInstitutionIntentionInvestmentsLearningLettersMalignant NeoplasmsMissionModelingModificationNative AmericansObesityOutreach ResearchPharmaceutical PreparationsPilot ProjectsPopulationPopulation HeterogeneityPopulation ResearchRecommendationResearch DesignResearch PersonnelRuralScientistSocietiesStructureSystemTimeTrainingTranslational ResearchUniversitiesWorkWritingclinical infrastructurecommunity engagementdesignhealth care qualityhealth equityhealth inequalitieshospitalization ratesimprovedinnovationmembermultiple chronic conditionspopulation healthprogramsracial diversityrecruittranslational research programtranslational scientist
项目摘要
ABSTRACT- OVERALL
This proposal is a competitive renewal of the Institutional Development Award Program Infrastructure for
Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013 to the
University of Delaware. The ACCEL CTR Program, has completed nine years of funding at the time of
this application. During our third funding cycle (ACCEL3), our consortium will consist of four partners:
University of Delaware (UD)—the lead institution; Nemours Children’s Health (Nemours); Christiana
Care Health System (CCHS), the largest health care system in Delaware; and Delaware State University
(DSU), an American historically Black, public university that joined our consortium during the last
competitive renewal. Over the past nine years, ACCEL has established an exceedingly strong network
and infrastructure for clinical and translational (C&T) research within the state of Delaware; and, we are
now poised and ready to continue our growth trajectory. While we will continue with the activities that
have made us successful, we will have a sharper focus on building sustainable infrastructure across
the state that can continue to thrive and mature for years to come. And, we will focus on creating a
scientific culture focused, not only, on improving the health of Delawareans, but doing so through a lens
of health equity. In our mission to establish a cadre of successful C&T scientists in DE, we will use
various approaches to promote full consideration of how their work impacts the needs of all members of
society, from design to study implementation to dissemination of findings. And, we will have a much
greater focus on building a bi-directional relationship between our scientists and the community so that
we can have a greater impact on Delawareans. Delaware is an ideal state for a CTR grant as it
represents the whole of the USA in a compact form. The population of Delaware (~970,000) mirrors the
US population in urban-to-rural citizen ratio and ethnic/racial diversity, with 23% African American, 62%
Caucasian, 10% Hispanic, 4% Asian and 1% Native American. Thus, studies involving a cross-section of
Delaware can be generalizable to populations nationally. The dominance of adult (CCHS) and pediatric
(Nemours) hospital systems, which serve at least 85% of the residents of the state, provides a unique
opportunity to treat the state of Delaware as a model for examining how healthcare changes can impact
population health. The overarching goal of the ACCEL CTR Program is to create a unified Delaware
Clinical and Translational Research Community (inclusive of investigators and community members) that
breaks down existing barriers, capitalizes on the unique strengths of its partners to establish
infrastructure and accelerates the creation of equitable solutions that improve the health of all
Delawareans and all Americans.
摘要-总体
该提案是机构发展奖励计划基础设施的竞争性更新,
临床和转化研究(IDEA-CTR)(U 54)补助金最初于2013年9月授予
特拉华州大学。ACCEL CTR计划在2009年完成了九年的资助,
这个应用程序。在我们的第三个融资周期(ACCEL 3),我们的财团将由四个合作伙伴组成:
特拉华州大学(UD)-牵头机构;内穆尔儿童健康中心(Nemours); Christiana
护理卫生系统(CCHS),特拉华州最大的卫生保健系统;和特拉华州州立大学
(DSU)这是一所美国历史上的黑人公立大学,去年加入了我们的联盟。
竞争性更新。在过去的九年里,ACCEL已经建立了一个非常强大的网络
以及特拉华州内临床和转化(C&T)研究的基础设施;而且,我们是
现在已经准备好继续我们的增长轨迹。虽然我们将继续开展活动,
使我们取得成功,我们将更加专注于建设可持续的基础设施,
一个可以在未来几年继续繁荣和成熟的国家。而且,我们将专注于创建一个
科学文化不仅关注于改善特拉华人的健康,而且通过透镜来实现这一目标
健康公平。在我们的使命,建立一个成功的C&T的科学家在DE干部,我们将使用
采取各种办法,促进充分考虑其工作如何影响到联合国所有成员的需要,
从设计到研究实施再到研究结果的传播。我们会有很多
更加注重在我们的科学家和社区之间建立双向关系,
我们可以对特拉华人产生更大的影响。特拉华州是CTR补助金的理想州,因为它
以紧凑的形式代表整个美国。特拉华州的人口(约97万)反映了
美国人口的城乡公民比例和民族/种族多样性,其中非洲裔美国人占23%,
白人,10%西班牙裔,4%亚洲人和1%美洲原住民。因此,研究涉及的横截面,
特拉华州可以推广到全国人口。成人(CCHS)和儿童的优势
(Nemours)医院系统为该州至少85%的居民提供服务,
有机会将特拉华州作为一个模型,研究医疗改革如何影响
人口健康。ACCEL CTR计划的首要目标是创建一个统一的特拉华州
临床和转化研究社区(包括研究者和社区成员),
打破现有障碍,利用合作伙伴的独特优势,
基础设施,并加快创造公平的解决方案,改善所有人的健康
特拉华人和所有美国人。
项目成果
期刊论文数量(287)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.
- DOI:10.1007/s40256-015-0131-6
- 发表时间:2015-12
- 期刊:
- 影响因子:0
- 作者:Fanari Z;Weiss S;Weintraub WS
- 通讯作者:Weintraub WS
Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.
用于成人和儿童癌症治疗的细胞周期抑制剂化疗的开发。
- DOI:10.1158/0008-5472.can-17-2782
- 发表时间:2018-01-15
- 期刊:
- 影响因子:11.2
- 作者:Mills CC;Kolb EA;Sampson VB
- 通讯作者:Sampson VB
Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus.
- DOI:10.1111/pedi.12241
- 发表时间:2015-03
- 期刊:
- 影响因子:3.4
- 作者:McCulloch MA;Mauras N;Canas JA;Hossain J;Sikes KM;Damaso LC;Redheuil A;Ross JL;Gidding SS
- 通讯作者:Gidding SS
Congenitally Corrected Transposition of the Great Arteries: Fetal Diagnosis, Associations, and Postnatal Outcome: A Fetal Heart Society Research Collaborative Study.
- DOI:10.1161/jaha.122.029706
- 发表时间:2023-06-06
- 期刊:
- 影响因子:5.4
- 作者:Cohen J;Arya B;Caplan R;Donofrio MT;Ferdman D;Harrington JK;Ho DY;Hogan W;Hornberger LK;Jhaveri S;Killen SAS;Lindblade CL;Michelfelder E;Moon-Grady AJ;Patel S;Quezada E;Ronai C;Sanchez Mejia AA;Schidlow DN;Stiver C;Thakur V;Srivastava S
- 通讯作者:Srivastava S
Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
- DOI:10.1016/j.amjcard.2013.07.034
- 发表时间:2013-12-01
- 期刊:
- 影响因子:0
- 作者:Sedlis SP;Jurkovitz CT;Hartigan PM;Kolm P;Goldfarb DS;Lorin JD;Dada M;Maron DJ;Spertus JA;Mancini GB;Teo KK;Boden WE;Weintraub WS;COURAGE Study Investigators
- 通讯作者:COURAGE Study Investigators
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory E Hicks其他文献
Gregory E Hicks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory E Hicks', 18)}}的其他基金
Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
- 批准号:
10686197 - 财政年份:2022
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10437677 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
- 批准号:
10892513 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10841849 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10721011 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Admin Core
特拉华州临床和转化研究 ACCEL 计划-管理核心
- 批准号:
10437678 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
- 批准号:
10372245 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
- 批准号:
10728055 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
- 批准号:
10721012 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
Improving Pediatric COVID-19 Vaccine Awareness, Access, and Accountability in Underrepresented Communities
提高代表性不足社区的儿童 COVID-19 疫苗意识、可及性和责任感
- 批准号:
10399062 - 财政年份:2013
- 资助金额:
$ 20.91万 - 项目类别:
相似海外基金
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10509308 - 财政年份:2022
- 资助金额:
$ 20.91万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10680412 - 财政年份:2022
- 资助金额:
$ 20.91万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10535890 - 财政年份:2022
- 资助金额:
$ 20.91万 - 项目类别:
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10629374 - 财政年份:2022
- 资助金额:
$ 20.91万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10553725 - 财政年份:2021
- 资助金额:
$ 20.91万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10494191 - 财政年份:2021
- 资助金额:
$ 20.91万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10328955 - 财政年份:2021
- 资助金额:
$ 20.91万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10437374 - 财政年份:2021
- 资助金额:
$ 20.91万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10654831 - 财政年份:2021
- 资助金额:
$ 20.91万 - 项目类别:
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
针对农村年轻非裔美国男性的戒烟干预措施的制定、实施和评估:走向可扩展性
- 批准号:
9896786 - 财政年份:2018
- 资助金额:
$ 20.91万 - 项目类别: